Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Adenosine impairs the proliferative capacity of terminally mature NK cells

ABSTRACT: Adenosine impairs the proliferative capacity of terminally mature NK cells

PROVIDER: PRJEB22631 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR2119810.fastq.gz	Fastqsanger.gz
	ERR2119811.fastq.gz	Fastqsanger.gz
	ERR2119802.fastq.gz	Fastqsanger.gz
	ERR2119812.fastq.gz	Fastqsanger.gz
	ERR2119803.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Liver-Specific Overexpression of HKDC1 Increases Hepatocyte Size and Proliferative Capacity

Project description:Liver-Specific Overexpression of HKDC1 Increases Hepatocyte Size and Proliferative Capacity

| PRJNA945469 | ENA

Dietary cystine restriction increases the proliferative capacity of the small intestine of mice

Project description:Dietary cystine restriction increases the proliferative capacity of the small intestine of mice

| PRJNA982067 | ENA

Dietary cystine restriction increases the proliferative capacity of the small intestine of mice

Project description:Dietary cystine restriction increases the proliferative capacity of the small intestine of mice

| PRJEB63227 | ENA

Conversion of terminally committed hepatocytes to culturable bipotent progenitor cells with regenerative capacity

Project description:A challenge for advancing approaches to liver regeneration is loss of functional differentiation capacity when hepatocyte progenitors are maintained in culture. Recent lineage-tracing studies have shown that mature hepatocytes (MHs) convert to an immature state during chronic liver injury, and we investigated whether this conversion could be recapitulated in vitro and if such converted cells could represent a source of expandable hepatocytes. We report that a cocktail of small molecules, Y-27632, A-83-01 and CHIR99021, can convert rat and mouse MHs in vitro into proliferative bipotent cells, which we term chemically induced liver progenitors (CLiPs). CLiPs can differentiate into both MHs and biliary epithelial cells that can form functional ductal structures. CLiPs in long-term culture did not lose their proliferative capacity or their hepatic differentiation ability, and rat CLiPs were shown to extensively repopulate chronically injured liver tissue. Thus our study advances the goals of liver regenerative medicine. Transcriptomic analyses for freshly isolated MHs and cells cultured for the designated periods with or without YAC stimulation (Matrix 1). Transcriptomic analysis for CLiPs which underwent hepatic induction (Matrix 2). Transcriptomic comparison of hepatic inducibility between CLiPs at early passage and those at late passages (Matrix 3). Transcriptomic comparison between chimera-derived rat cells (designated as “2nd”) and primary rat MH-derived cells (designated as “1st”) (Matrix 4).

2016-11-15 | GSE87611 | GEO

TIM-3 + CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies

Project description:TIM-3 + CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies

| PRJNA1091196 | ENA

Adenosine induced gene expression

Project description:HCT116 cells are treated by adenosine (4 mM) for 6 hours and then using total RNA for sequencing analysis to evaluate adenosine induced gene expression.

2023-11-29 | GSE216006 | GEO

Adenosine induced gene expression

Project description:Adenosine induced gene expression

| PRJNA891699 | ENA

Rat MeDIP Array, naïve, epileptic, and adenosine treated

Project description:Epilepsy causes altered gene expression; transient adenosine treatment inhibits progression of epileptogenesis Hippocampus of epileptic rat is hypermethylated compared to naïve; adenosine treatment causes hypomethylation Metylation state in epileptic rats (9 weeks post kainic acid induced status epilepticus) was compared to naïve (untreated) rats and epileptic rats treated with adenosine for 5 days

2013-09-05 | E-GEOD-45932 | biostudies-arrayexpress

Adenosine-treated endothelial progenitor cells

Project description:The goal of this study was to investigate the effects of the cardioprotective nucleoside adenosine on gene expression in early and late endothelial progenitor cells. Adenosine mod

2011-01-29 | GSE26744 | GEO

Palbociclib impairs the proliferative capacity of activated T cells while retaining their cytotoxic efficacy.

Project description:The cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor palbociclib is an emerging cancer therapeutic that just recently gained Food and Drug Administration approval for treatment of estrogen receptor (ER)-positive, human epidermal growth factor receptor (Her)2-negative breast cancer in combination with the ER degrader fulvestrant. However, CDK4/6 inhibitors are not cancer-specific and may affect also other proliferating cells. Given the importance of T cells in antitumor defense, we studied the influence of palbociclib/fulvestrant on human CD3+ T cells and novel emerging T cell-based cancer immunotherapies. Palbociclib considerably inhibited the proliferation of activated T cells by mediating G0/G1 cell cycle arrest. However, after stopping the drug supply this suppression was fully reversible. In light of combination approaches, we further investigated the effect of palbociclib/fulvestrant on T cell-based immunotherapies by using a CD3-PSCA bispecific antibody or universal chimeric antigen receptor (UniCAR) T cells. Thereby, we observed that palbociclib clearly impaired T cell expansion. This effect resulted in a lower total concentration of interferon-γ and tumor necrosis factor, while palbociclib did not inhibit the average cytokine release per cell. In addition, the cytotoxic potential of the redirected T cells was unaffected by palbociclib and fulvestrant. Overall, these novel findings may have implications for the design of treatment modalities combining CDK4/6 inhibition and T cell-based cancer immunotherapeutic strategies.

| S-EPMC9935825 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data